(Q28253182)

5

Göran Roos

0 references

Mats Jerkeman

9

Mats Jerkeman

0 references

Gunilla Enblad

16

Gunilla Enblad

0 references

Hans Hagberg

14

Hans Hagberg

0 references

author name string

Mattias Berglund

1

0 references

Ulf Thunberg

2

0 references

Rose-Marie Amini

3

0 references

Majlis Book

4

0 references

Martin Erlanson

6

0 references

Johan Linderoth

7

0 references

Michael Dictor

8

0 references

Christer Sundström

11

0 references

Suzanne Rehn-Eriksson

12

0 references

Carin Backlin

13

0 references

Richard Rosenquist

Diffuse large cell lymphoma

15

0 references

language of work or name

English

0 references

publication date

August 2005

0 references

published in

Modern Pathology

0 references

volume

18

0 references

issue

8

0 references

page(s)

1113-20

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Detection of germinal center B-cell lymphoma in archival specimens: critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Building an outcome predictor model for diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Acetylation inactivates the transcriptional repressor BCL6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Increased Expression of the bcl6 and CD10 Proteins Is Associated with Increased Apoptosis and Proliferation in Diffuse Large B-Cell Lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

The clinical significance of CD10 antigen expression in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Regulation of lymphocyte apoptosis by interferon regulatory factor 4 (IRF-4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

BCL2 overexpression in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

7 January 2021

Prognostic significance of bcl‐2, bax, and p53 expression in diffuse large B‐cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

7 January 2021

Immunohistochemical analysis of B-cell lymphoma using tissue microarrays identifies particular phenotypic profiles of B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

7 January 2021

CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

7 January 2021

Causes and consequences of BCL2 overexpression in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

7 January 2021

Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800396

7 January 2021